LENSAR (LNSR) Competitors

Iradimed (NASDAQ:IRMD) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, community ranking, dividends, media sentiment, valuation and earnings.

Does the media prefer IRMD or LNSR?

In the previous week, Iradimed had 5 more articles in the media than LENSAR. MarketBeat recorded 6 mentions for Iradimed and 1 mentions for LENSAR. Iradimed's average media sentiment score of 1.37 beat LENSAR's score of 0.50 indicating that Iradimed is being referred to more favorably in the media.

Company	Overall Sentiment
Iradimed	Positive
LENSAR	Positive

Do analysts rate IRMD or LNSR?

Iradimed currently has a consensus target price of $72.00, indicating a potential upside of 39.08%. LENSAR has a consensus target price of $15.00, indicating a potential upside of 7.84%. Given Iradimed's stronger consensus rating and higher probable upside, equities analysts clearly believe Iradimed is more favorable than LENSAR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iradimed	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
LENSAR	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has better valuation & earnings, IRMD or LNSR?

Iradimed has higher revenue and earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iradimed	$73.24M	8.99	$19.23M	$1.50	34.51
LENSAR	$53.49M	3.07	-$14.38M	-$2.72	-5.11

Do insiders and institutionals hold more shares of IRMD or LNSR?

92.3% of Iradimed shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 37.1% of Iradimed shares are held by insiders. Comparatively, 38.5% of LENSAR shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is IRMD or LNSR more profitable?

Iradimed has a net margin of 26.26% compared to LENSAR's net margin of -34.03%. Iradimed's return on equity of 24.12% beat LENSAR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iradimed	26.26%	24.12%	21.20%
LENSAR	-34.03%	-49.02%	-21.12%

Which has more risk & volatility, IRMD or LNSR?

Iradimed has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.

Does the MarketBeat Community favor IRMD or LNSR?

Iradimed received 253 more outperform votes than LENSAR when rated by MarketBeat users. Likewise, 65.40% of users gave Iradimed an outperform vote while only 37.50% of users gave LENSAR an outperform vote.

Company	Underperform	Outperform
Iradimed	Outperform Votes 259 65.40%	Underperform Votes 137 34.60%
LENSAR	Outperform Votes 6 37.50%	Underperform Votes 10 62.50%

Summary

Iradimed beats LENSAR on 17 of the 18 factors compared between the two stocks.